Age, stress, diet, pollution, medication, trauma, and sun exposure can all deplete levels of this beauty antioxidant
Full informed consent is non-negotiable
A Phase I safety study and a Phase II ulcerative colitis trial of the BPC-157 formulation PL 14736 were conducted by the Croatian pharmaceutical company Pliva, but full peer-reviewed Phase II efficacy results have not been published
"Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial"
If youre working with an uncharacterized protein, or a protein for which a good antibody has not been developed (and just because your protein has a commercially available antibody, that doesnt mean its a good one), then your first step towards detecting, immunoprecipitating, or purifying that protein may be to fuse an affinity tag to it